High-count monoclonal B-cell lymphocytosis (MBL) is an asymptomatic state that can evolve into chronic lymphocytic leukemia (CLL) when B-cells gain a cancer-inducing combination of driver mutations. In a recently published study, MBL patient samples were analyzed using bulk targeted deep sequencing. The researchers found that in a subset of cases, there were a significant number of mutations -- in many cases, affecting the same genes.
To further gain insights into these MBL patient samples, single-cell DNA sequencing was performed on them using the Mission Bio Tapestri Platform and a 33-gene CLL amplicon panel. This application note shows that previously generated data from bulk sequencing were highly correlative to the newly generated single-cell data. The researchers unambiguously resolved co-occurrence and zygosity of all detected mutations to track clonal evolution and population expansion over time. These results show that single-cell DNA sequencing is a powerful tool for resolving clonal heterogeneity.
Offered Free by: MissionBio
See All Resources from: MissionBio
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.